Gudgeon JM - Search Results

1

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.

Meckley LM, Gudgeon JM, Anderson JL, Williams MS, Veenstra DL. Meckley LM, et al. Among authors: gudgeon jm. Pharmacoeconomics. 2010;28(1):61-74. doi: 10.2165/11318240-000000000-00000. Pharmacoeconomics. 2010. PMID: 20014877

2

Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing.

Gudgeon JM, McClain MR, Palomaki GE, Williams MS. Gudgeon JM, et al. Genet Med. 2007 Jul;9(7):473-8. doi: 10.1097/gim.0b013e3180a6e9ef. Genet Med. 2007. PMID: 17666894 Review.

3

Lynch syndrome screening implementation: business analysis by a healthcare system.

Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS. Gudgeon JM, et al. Am J Manag Care. 2011 Aug 1;17(8):e288-300. Am J Manag Care. 2011. PMID: 21851136 Free article.

4

Impact of age cutoffs on a lynch syndrome screening program.

Gudgeon JM, Belnap TW, Williams JL, Williams MS. Gudgeon JM, et al. J Oncol Pract. 2013 Jul;9(4):175-9. doi: 10.1200/JOP.2012.000573. Epub 2012 Nov 13. J Oncol Pract. 2013. PMID: 23942916 Free PMC article.

5

Is immunohistochemistry-based screening for Lynch syndrome in endometrial cancer effective? The consent's the thing.

Gudgeon JM, Varner MW, Hashibe M, Williams MS. Gudgeon JM, et al. Gynecol Oncol. 2019 Jul;154(1):131-137. doi: 10.1016/j.ygyno.2019.05.006. Epub 2019 May 23. Gynecol Oncol. 2019. PMID: 31130287

6

Model-Based Re-Examination of the Effectiveness of Tumor/Immunohistochemistry and Direct-to-Sequencing Protocols for Lynch Syndrome Case Finding in Endometrial Cancer.

Gudgeon JM, Varner MW, Hao J, Williams MS. Gudgeon JM, et al. JCO Oncol Pract. 2021 Nov;17(11):e1785-e1793. doi: 10.1200/OP.20.00988. Epub 2021 Apr 22. JCO Oncol Pract. 2021. PMID: 33886346

7

Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer.

Hao J, Hassen D, Gudgeon JM, Snyder SR, Hampel H, Williams MS, Sharaf RN, Lu CY, Williams JL, Schlieder V, Rahm AK. Hao J, et al. Among authors: gudgeon jm. J Pers Med. 2021 Dec 2;11(12):1284. doi: 10.3390/jpm11121284. J Pers Med. 2021. PMID: 34945755 Free PMC article.

8

Genetic testing for lynch syndrome in individuals newly diagnosed with colorectal cancer to reduce morbidity and mortality from colorectal cancer in their relatives.

Coates R, Williams M, Melillo S, Gudgeon J. Coates R, et al. PLoS Curr. 2011 Jul 6;3:RRN1246. doi: 10.1371/currents.RRN1246. PLoS Curr. 2011. PMID: 21743847 Free PMC article.

9

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.

Rahm AK, Cragun D, Hunter JE, Epstein MM, Lowery J, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Burnett-Hartman AN, Gudgeon JM, Hao J, Snyder S, Gogoi R, Ladd I, Williams MS. Rahm AK, et al. Among authors: gudgeon jm. BMC Health Serv Res. 2018 Oct 30;18(1):824. doi: 10.1186/s12913-018-3636-2. BMC Health Serv Res. 2018. PMID: 30376847 Free PMC article.

10

Determination of test performance of two contemporary screening tests for Lynch syndrome in endometrial cancer: A clinical trial.

Gudgeon JM, Wallentine JC, Bonham EM, McLaughlin HD, Dodson MK. Gudgeon JM, et al. Gynecol Oncol. 2022 Jan;164(1):34-38. doi: 10.1016/j.ygyno.2021.09.022. Epub 2021 Oct 21. Gynecol Oncol. 2022. PMID: 34689999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters